The company expired its plan on December 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.72 USD | +3.61% | +12.42% | +95.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+95.45% | 208M | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Atossa Therapeutics, Inc.'s Equity Buyback announced on June 27, 2023, has expired with 1,320,046 shares, representing 1.04% for $1.44 million.